Editorial
MellowLoop: A Reconfigurable Audio-Light Interaction System for Irritability Mitigation
@ARTICLE{10.4108/eetpht.11.11064, author={Junpeng Zheng and Yousheng Yao and Weibin Xu and Junqi Zhan and Lingna Tang and Shihua Quan}, title={MellowLoop: A Reconfigurable Audio-Light Interaction System for Irritability Mitigation}, journal={EAI Endorsed Transactions of Pervasive Health and Technology}, volume={11}, number={1}, publisher={EAI}, journal_a={PHAT}, year={2026}, month={1}, keywords={audio-light interaction, irritability, ambient intervention, equal-loudness, perfusion index, skin conductance level (SCL), pervasive health}, doi={10.4108/eetpht.11.11064} }- Junpeng Zheng
Yousheng Yao
Weibin Xu
Junqi Zhan
Lingna Tang
Shihua Quan
Year: 2026
MellowLoop: A Reconfigurable Audio-Light Interaction System for Irritability Mitigation
PHAT
EAI
DOI: 10.4108/eetpht.11.11064
Abstract
INTRODUCTION: Irritability is common in daily life and cuts across diagnoses, yet brief, non-drug options that can be delivered through everyday environments remain scarce. We developed MellowLoop, a reconfigurable audio–light object that synchronizes warm light and gentle sound using clearly defined, comfortable dose ranges. OBJECTIVES: To test whether a single, synchronized audio–light session reduces irritability more than either modality alone or a neutral control; to examine whether subjective changes are mirrored in a coherent physiological pattern; and to assess whether a simple, reconfigurable object can deliver this protocol in a way that is practical for pervasive health deployment. METHODS: We conducted a randomized, parallel, four-arm laboratory study with 60 adults allocated to multimodal audio+light, light-only, audio-only, or a neutral control scene. Each visit followed a fixed 5-minute baseline, 20-minute exposure, and 5-minute post-rest sequence. For active arms, sound was held at 55–60 dB(A) at the ear and light at 200–300 lux of warm (3000–3500 K) illuminance at the eye, guided by equal-loudness contours and melanopic references. Self-reported irritability, valence, and calmness were collected pre- and post-session, alongside skin conductance level, perfusion index, oxygen saturation, and heart rate. Outcomes were analyzed in a prespecified mixed-effects framework with planned contrasts between each active arm and control. RESULTS: The multimodal session produced the largest reduction in irritability, with smaller but still meaningful decreases in the two single-modality arms and minimal change in control. In parallel, valence and calmness increased most in the multimodal arm. Physiological signals showed a convergent pattern: skin conductance level decreased and perfusion index increased most under multimodal stimulation, heart rate declined modestly across active arms, and oxygen saturation remained high and stable. Target exposure levels were achieved with narrow variation, sessions were well tolerated, and no adverse events occurred. CONCLUSION: A single, well-calibrated audio–light session delivered by a reconfigurable everyday object can acutely ease irritability while remaining comfortable and feasible. The combination of a dose-defined protocol, multi-arm randomized design, and low-cost sensing chain offers a practical blueprint for future pervasive health systems that seek to embed irritability support into ordinary rooms and routines.
